AppliedVR Secures $29M Funding to Pursue FDA Approval for VR Pain Management Tech
Road to VR
MARCH 23, 2021
Based on cognitive behavioral therapies and mindfulness training, the company’s EaseVRx solution recently received Breakthrough Device Designation from the FDA for treatment-resistant fibromyalgia and chronic intractable lower back pain, something that is typically treated by prescribing opioids. .
Let's personalize your content